Emerging roles of secreted phospholipase A2 enzymes: Lessons from transgenic and knockout mice |
| |
Authors: | Makoto Murakami,Yoshitaka Taketomi,Christophe Girard,Kei Yamamoto,Gé rard Lambeau |
| |
Affiliation: | 1. Biomembrane Signaling Project, The Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan;2. Institut de Pharmacologie Moléculaire et Cellulaire, Université de Nice Sophia Antipolis et Centre National de la Recherche Scientifique, 660 route des Lucioles, Sophia Antipolis, 06560 Valbonne, France |
| |
Abstract: | Among the emerging phospholipase A2 (PLA2) superfamily, the secreted PLA2 (sPLA2) family consists of low-molecular-mass, Ca2+-requiring extracellular enzymes with a His-Asp catalytic dyad. To date, more than 10 sPLA2 enzymes have been identified in mammals. Individual sPLA2s exhibit unique tissue and cellular localizations and enzymatic properties, suggesting their distinct pathophysiological roles. Despite numerous enzymatic and cell biological studies on this enzyme family in the past two decades, their precise in vivo functions still remain largely obscure. Recent studies using transgenic and knockout mice for several sPLA2 enzymes, in combination with lipidomics approaches, have opened new insights into their distinct contributions to various biological events such as food digestion, host defense, inflammation, asthma and atherosclerosis. In this article, we overview the latest understanding of the pathophysiological functions of individual sPLA2 isoforms fueled by studies employing transgenic and knockout mice for several sPLA2s. |
| |
Keywords: | Phospholipase A2 Lipid mediator Inflammation Asthma Atherosclerosis |
本文献已被 ScienceDirect 等数据库收录! |
|